XML 36 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)
 3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
REVENUES:    
License fees $ 319,146us-gaap_LicensesRevenue $ 294,504us-gaap_LicensesRevenue
Royalties from product sales 156,550us-gaap_RoyaltyRevenue 97,886us-gaap_RoyaltyRevenue
Grant income 698,839us-gaap_RevenueFromGrants 575,659us-gaap_RevenueFromGrants
Sale of research products and services 89,919us-gaap_SalesRevenueGoodsNet 98,586us-gaap_SalesRevenueGoodsNet
Total revenues 1,264,454us-gaap_SalesRevenueNet 1,066,635us-gaap_SalesRevenueNet
Cost of sales (264,167)us-gaap_CostOfRevenue (131,914)us-gaap_CostOfRevenue
Gross Profit 1,000,287us-gaap_GrossProfit 934,721us-gaap_GrossProfit
OPERATING EXPENSES:    
Research and development 9,323,510us-gaap_ResearchAndDevelopmentExpense 8,405,393us-gaap_ResearchAndDevelopmentExpense
General and administrative 5,178,800us-gaap_GeneralAndAdministrativeExpense 3,667,171us-gaap_GeneralAndAdministrativeExpense
Total operating expenses 14,502,310us-gaap_OperatingExpenses 12,072,564us-gaap_OperatingExpenses
Loss from operations (13,502,023)us-gaap_OperatingIncomeLoss (11,137,843)us-gaap_OperatingIncomeLoss
OTHER INCOME/(EXPENSES):    
Interest expense, net (25,461)us-gaap_InterestIncomeExpenseNet (8,384)us-gaap_InterestIncomeExpenseNet
Other income/(expense), net (239,453)us-gaap_OtherNonoperatingIncome 69,170us-gaap_OtherNonoperatingIncome
Total other income/(expenses), net (264,914)us-gaap_NonoperatingIncomeExpense 60,786us-gaap_NonoperatingIncomeExpense
LOSS BEFORE INCOME TAX BENEFITS (13,766,937)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest (11,077,057)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Deferred income tax benefit 1,176,882us-gaap_DeferredIncomeTaxExpenseBenefit 1,349,026us-gaap_DeferredIncomeTaxExpenseBenefit
NET LOSS (12,590,055)us-gaap_ProfitLoss (9,728,031)us-gaap_ProfitLoss
Net loss attributable to non-controlling interest 2,422,687us-gaap_NetIncomeLossAttributableToNoncontrollingInterest 1,629,017us-gaap_NetIncomeLossAttributableToNoncontrollingInterest
NET LOSS ATTRIBUTABLE TO BIOTIME, INC. $ (10,167,368)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic $ (8,099,014)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic
BASIC AND DILUTED NET LOSS PER COMMON SHARE (in dollars per share) $ (0.13)us-gaap_EarningsPerShareBasicAndDiluted $ (0.14)us-gaap_EarningsPerShareBasicAndDiluted
WEIGHTED AVERAGE NUMBER OF COMMON STOCK OUTSTANDING: BASIC AND DILUTED (in shares) 78,261,788us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 58,257,427us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted